“We aspire to be the most respected and valued biotech by having the most number of compounds in the clinic of any Indian company to address the unmet needs in Oncology and Inflammation”.

In order to realize this Vision, Aurigene has pioneered a uniquely collaborative model of discovery with pharmacos and biotechs.

Aurigene was established in 2002 as one of India’s first biotechs and has consistently worked on a business model focussed on early-stage partnering with large and mid-sized pharma companies. Over the years, Aurigene has become a strategic partner for its customers, focused around several themes on which the partnerships have been built: Therapeutic area, target pathway or business strategy.

Today with a strong, successful track record, Aurigene has evolved as a specialized discovery stage biotech focussed on some of the emerging areas of science in oncology and inflammation.